PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 22, 2026Pediatrics International0 citationsOpen Access

Decision‐Making Regarding the Administration of Live Vaccines to Patients With a FOXN1 Heterozygous Missense Variant

View Full Paper
MYMotoko YasutomiYIYuko IsozakiTOTakashi Okuno

Key Points

  • To evaluate decision-making regarding live vaccine administration for an infant with a FOXN1 heterozygous variant identified through mass screening.
  • Assessed T-cell receptor excision circle (TREC) levels and other immune parameters in a newborn with FOXN1-Het variant.
  • Administered inactivated vaccines based on immune function, while withholding live vaccines based on TREC levels and clinical findings.
  • Conducted gene analysis and monitored immune responses over time.
  • Identified FOXN1 heterozygous missense variant with low TREC levels indicating possible severe immunodeficiency.
  • Inactivated vaccines resulted in protective antibody levels without adverse events, while live vaccines were administered later after TREC normalization.
  • Ongoing monitoring showed sustained CD4+ counts and improved immune function, guiding vaccination decisions.

Abstract

FOXN1 is an essential transcription factor for thymic epithelial cell differentiation and consequently, naïve T cell development. Homozygous (Hom) FOXN1 variants cause T-lymphopenia, alopecia universalis, and nail dystrophy 1. However, the phenotypic manifestations of heterozygous (Het) FOXN1 variants range from healthy to severe immunodeficiency. Herein we report the decision-making process regarding administration of live vaccines to an infant with a FOXN1-Het variant identified through newborn mass screening. A 21-day-old male neonate was suspected of having severe combined immunodeficiency (SCID) due to a low T-cell receptor excision circle (TREC) level (6.9 copies/μL [cut-off 500/μL and the CD8+ counts exceeded normal lower limits. The naïve CD4+ counts increased transiently, followed by normalization of TREC levels (Figure 1B,C). At 16 months of age the child was administered live vaccines except for Bacillus Calmette–Guérin (BCG). Following the vaccination, antibody responses were detected by enzyme-immunoassay without adverse events: anti-measles IgG, 11.3; anti-rubella IgG, 2.1; and anti-varicella zoster IgG, 2.4 (all with a normal cutoff of 500/μL after 1 year of age, and an increase in the IgG levels were helpful indicators for the administration of live vaccines. In conclusion, repetitive quantification of the TREC level not only served as a trigger for gene analysis but also helped decision-making regarding the administration of live vaccines to a patient with a FOXN1-Het variant. M.Y.-S. wrote the manuscript and Y.O. revised it and supervised the whole study process. Y.I. and T.O. treated the patient and collected the data. M.Y. organized newborn mass screening. All authors read and approved the final manuscript. I would like to thank Prof. Kohsuke Imai of the department of pediatrics, National defense medical college for his advice regarding vaccines. Informed consent for the publication of this report was obtained from the parents. The authors declare no conflicts of interest. Data sharing not applicable to this article as no datasets were generated or analysed during the current study.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Yasutomi et al. (2026) studied this question.

synapsesocial.com/papers/69e864ec6e0dea528dde9885https://doi.org/10.1111/ped.70391
Ask AI
Helpful
Bookmark
Share
View Full Paper